Evidence map›Paper›PMID 37063715›Full record

ArticleRSC advances2023

Efficient dispersive solid-phase extraction of methylprednisolone from exhaled breath of COVID-19 patients.

Yasaman Sefid-Sefidehkhan, Mehdi Mokhtari, Ata Mahmoodpoor, Yosra Vaez-Gharamaleki, Maryam Khoubnasabjafari, Mohammad Reza Afshar Moghaddam, Vahid Jouyban-Gharamaleki, Siavoush Dastmalchi, Elaheh Rahimpour, Abolghasem Jouyban

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yasaman Sefid-SefidehkhanPharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences Tabriz Iran rahimpour_e@yahoo.com.
Mehdi MokhtariImmunology Research Center, Tabriz University of Medical Sciences Tabriz Iran.
Ata MahmoodpoorDepartment of Anesthesiology and Intensive Care, Faculty of Medicine, Tabriz University of Medical Sciences Tabriz Iran.
Yosra Vaez-GharamalekiHematology - Oncology Research Center, Tabriz University of Medical Sciences Tabriz Iran.
Maryam KhoubnasabjafariTuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences Tabriz Iran.
Mohammad Reza Afshar MoghaddamFood and Drug Safety Research Center, Tabriz University of Medical Sciences Tabriz Iran.
Vahid Jouyban-GharamalekiKimia Idea Pardaz Azarbayjan (KIPA) Science Based Company, Tabriz University of Medical Sciences Tabriz Iran.
Siavoush DastmalchiBiotechnology Research Center, Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0001-9427-0770
Elaheh RahimpourPharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences Tabriz Iran rahimpour_e@yahoo.com.ORCID https://orcid.org/0000-0002-4037-9436
Abolghasem JouybanPharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences Tabriz Iran rahimpour_e@yahoo.com.ORCID https://orcid.org/0000-0002-4670-2783
Tabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current study, bismuth ferrite nano-sorbent was synthesized and utilized as a sorbent for the dispersive solid-phase extraction of methylprednisolone from exhaled breath samples. The size and morphology of the nano-sorbent were characterized by X-ray diffraction analysis and scanning electron microscopy. Following its desorption with acetonitrile, methylprednisolone was quantified by a high-performance liquid chromatography-ultraviolet detector. Factors affecting the extraction of methylprednisolone were optimized. Under optimized experimental conditions, a linear relationship between the analytical signals and methylprednisolone concentration was obtained in the range of 0.001-0.2 μg mL

Identifiers

PMID37063715
PMCPMC10090898
OpenAlexW4365396090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.